Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Conditions

Lymphatic Abnormalities 1Lymphangioma, Cystic 1Lymphangioma 1

Interventions

sargramostim 3Methods 3Granulocyte-Macrophage Colony-Stimulating Factor 3Exercise 3Colonoscopy 3Prednisone 2Palliative Care 2Leuprolide 2Golytely 2Gelatin 2Decision Support Techniques 2Collagenases 2Clofarabine 2Cholecalciferol 2Calcitriol 2ADI PEG20 2talabostat 1sulforaphane 1apalutamide 1abiraterone 1Yoga 1Water 1Tretinoin 1Topotecan 1Thioctic Acid 1Tablets 1Surgical Instruments 1Streptozocin 1Standard of Care 1Social Work 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × FED × Picibanil × Clear all
NCT00010452 2015-03-25

Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations

FDA Office of Orphan Products Development

Phase 2/3 Completed
150 enrolled

Lymphangioma, Lymphangioma, Cystic, Lymphatic Abnormalities

Data powered by HemOnc (CC BY 4.0) Colophon âš¡